文献速递妇科肿瘤

ENDORISK-2:整合分子分型与术前肌层浸润评估的子宫内膜癌术前风险分层贝叶斯网络

ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment.
PubMed 文献 · Eur J Cancer · 2025-10-19

ENDORISK-2 是在 ENDORISK 基础上整合分子分型(POLE、MSI)和术前肌层浸润评估(经阴道超声或盆腔 MRI)的贝叶斯网络,用于预测子宫内膜癌淋巴结转移风险。在两个独立外部队列(Brno n=581;

核心结论

  • 整合分子数据和术前肌层浸润评估提高了 ENDORISK 的灵活性,预测 LNM 的诊断准确性与基于低成本免疫组化标志物时相当。
  • 在低级别子宫内膜癌患者中诊断准确性高,ENDORISK-2 可帮助临床医生识别可安全省略手术淋巴结评估的患者。
  • 结果支持其在高资源和低资源国家临床使用的潜力。

研究设计与样本

  • ENDORISK-2 是在 ENDORISK 贝叶斯网络基础上优化开发,新增 POLE、MSI 和术前肌层浸润评估(经阴道超声或盆腔 MRI)变量,p53 已包含在 ENDORISK 中。
  • 在 Brno(CZ)队列 n=581 和 Tübingen(DE)队列 n=247 两个独立外部队列中验证 LNM 预测。

临床怎么用

  • ENDORISK-2 可用于术前预测子宫内膜癌患者 LNM 风险,辅助识别可安全省略手术淋巴结评估的低级别患者。
  • 在资源有限地区,可用原最小变量集(术前分级、三个 IHC 标志物和一个临床标志物)替代新变量,诊断准确性可比。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: ENDORISK is a Bayesian network that can assist in preoperative risk estimation of lymph node metastasis (LNM) risk in endometrial cancer (EC) with consistent performance in external validations. To reflect state of the art care, ENDORISK was optimized by integrating molecular classification and preoperative assessment of myometrial invasion (MI). METHODS: Variables for POLE, MSI, and preoperative assessment of MI, either by expert transvaginal ultrasound or pelvic magnetic resonance imaging (MRI), were added to develop ENDORISK-2. The p53 biomarker, part of the molecular classification, was already included in ENDORISK. External validation of ENDORISK-2 for LNM prediction was performed in two independent cohorts from: Brno (CZ), (n = 581) and Tübingen (DE), (n = 247). FINDINGS: ENDORISK-2 yielded AUCs of 0·85 (95 % CI 0·80-0·90) (CZ) and 0·86 (95 % CI 0·77-0·96) (DE) for predicting LNM. In patients with low-grade histology, 83 % (CZ) and 89 % (DE) were estimated having less than 10 % risk of LNM, with false negative rates (FNR) of 4·3 % (CZ) and 2·2 % (DE). The previously defined set of minimally required variables, i.e.: preoperative tumor grade, three of the four immunohistochemical (IHC) markers, and one clinical marker, could be interchanged with the new variables, with comparable validation metrics, including AUC values of 0·79-0·87 for LNM prediction. INTERPRETATION: Incorporation of molecular data and preoperative MI improved the flexibility of ENDORISK with comparable diagnostic accuracy for estimating LNM as when based on low-cost immunohistochemical biomarkers. In addition, the high diagnostic accuracy in patients with low-grade EC demonstrates how ENDORISK-2 could aid clinicians in identifying patients in whom surgical lymph node assessment may safely be omitted. These results underline its power for clinical use in both high and low resource countries.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Lombaers MS, Reijnen C, Sprik A, et al. ENDORISK-2: A personalized Bayesian network for preoperative risk stratification in endometrial cancer, integrating molecular classification and preoperative myometrial invasion assessment. Eur J Cancer. 2025. PMID: 41161057. doi:10.1016/j.ejca.2025.116058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。